Exact Mass: 335.1845

Exact Mass Matches: 335.1845

Found 115 metabolites which its exact mass value is equals to given mass value 335.1845, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Hydroxychloroquine

7-Chloro-4-(4-(N-ethyl-N-beta-hydroxyethylamino)-1-methylbutylamino)quinoline

C18H26ClN3O (335.1764)


Hydroxychloroquine is only found in individuals that have used or taken this drug. It is a chemotherapeutic agent that acts against erythrocytic forms of malarial parasites.Although the exact mechanism of action is unknown, it may be based on ability of hydroxychloroquine to bind to and alter DNA. Hydroxychloroquine has also has been found to be taken up into the acidic food vacuoles of the parasite in the erythrocyte. This increases the pH of the acid vesicles, interfering with vesicle functions and possibly inhibiting phospholipid metabolism. In suppressive treatment, hydroxychloroquine inhibits the erythrocytic stage of development of plasmodia. In acute attacks of malaria, it interrupts erythrocytic schizogony of the parasite. Its ability to concentrate in parasitized erythrocytes may account for their selective toxicity against the erythrocytic stages of plasmodial infection. As an antirheumatic, hydroxychloroquine is thought to act as a mild immunosuppressant, inhibiting the production of rheumatoid factor and acute phase reactants. It also accumulates in white blood cells, stabilizing lysosomal membranes and inhibiting the activity of many enzymes, including collagenase and the proteases that cause cartilage breakdown. P - Antiparasitic products, insecticides and repellents > P01 - Antiprotozoals > P01B - Antimalarials > P01BA - Aminoquinolines COVID info from Guide to PHARMACOLOGY, clinicaltrial, clinicaltrials, clinical trial, clinical trials D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C277 - Antiprotozoal Agent D018501 - Antirheumatic Agents D004791 - Enzyme Inhibitors Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

   

Lobelanine

2-[(2S,6R)-1-methyl-6-(2-oxo-2-phenyl-ethyl)piperidin-2-yl]-1-phenyl-ethanone

C22H25NO2 (335.1885)


Lobelanine is a member of acetophenones. Lobelanine is a natural product found in Lobelia sessilifolia, Lobelia inflata, and other organisms with data available. Lobelanine (8,10-Diphenyllobelidione) is a chemical precursor for the biosynthesis of Lobeline. Lobeline is a partial nicotinic agonist and is used as a smoking cessation agent[1][2]. Lobelanine (8,10-Diphenyllobelidione) is a chemical precursor for the biosynthesis of Lobeline. Lobeline is a partial nicotinic agonist and is used as a smoking cessation agent[1][2].

   

N-2-[4-(3,3-Dimethylallyloxy)phenyl]ethylcinnamide

(Z,2Z)-N-(2-{4-[(3-methylbut-2-en-1-yl)oxy]phenyl}ethyl)-3-phenylpropa-2-enimidic acid

C22H25NO2 (335.1885)


N-2-[4-(3,3-Dimethylallyloxy)phenyl]ethylcinnamide is found in fruits. N-2-[4-(3,3-Dimethylallyloxy)phenyl]ethylcinnamide is an alkaloid from the leaves of Aegle marmelos (bael fruit

   

2-(2-Methoxyphenyl)-1-(1-pentylindol-3-yl)ethanone

2-(2-methoxyphenyl)-1-(1-pentyl-1H-indol-3-yl)ethan-1-one

C22H25NO2 (335.1885)


   

alpha-Pentyl-3-(2-quinolinylmethoxy)benzenemethanol

alpha-Pentyl-3-(2-quinolinylmethoxy)benzenemethanol

C22H25NO2 (335.1885)


   

Oryzamutaic acid D

Oryzamutaic acid D

C17H25N3O4 (335.1845)


   

Oryzamutaic acid E

Oryzamutaic acid E

C17H25N3O4 (335.1845)


   

Oryzamutaic acid F

Oryzamutaic acid F

C17H25N3O4 (335.1845)


   

Oryzamutaic acid G

Oryzamutaic acid G

C17H25N3O4 (335.1845)


   

oryzamutaic acid J

oryzamutaic acid J

C17H25N3O4 (335.1845)


   

JWH-250

2-(2-methoxyphenyl)-1-(1-pentyl-1H-indol-3-yl)-ethanone

C22H25NO2 (335.1885)


   
   
   

Oprea1_633801

Oprea1_633801

C19H21N5O (335.1746)


   

MBP146-78

Pyridine, 4-[2-(4-fluorophenyl)-5-(1-methyl-4-piperidinyl)-1H-pyrrol-3-yl]-

C21H22FN3 (335.1798)


   

Alkaloid KD-2

Alkaloid KD-2

C22H25NO2 (335.1885)


   

SCHEMBL12512075

SCHEMBL12512075

C17H25N3O4 (335.1845)


   

11-hydroxy-4,12-dimethyl-13-(2-methyl-1,3-thiazol-4-yl)trideca-8,12-dien-3-one

11-hydroxy-4,12-dimethyl-13-(2-methyl-1,3-thiazol-4-yl)trideca-8,12-dien-3-one

C19H29NO2S (335.1919)


   

4-Acetoxy-1,3,5,6-tetramethoxy-2-(N-methylacetylamino)hexane

4-Acetoxy-1,3,5,6-tetramethoxy-2-(N-methylacetylamino)hexane

C15H29NO7 (335.1944)


   

2-(1-methyl-6-phenacylpiperidin-2-yl)-1-phenylethanone

2-(1-methyl-6-phenacylpiperidin-2-yl)-1-phenylethanone

C22H25NO2 (335.1885)


   
   
   
   
   
   
   
   
   

Rev 5901

α-pentyl-3-(2-quinolinylmethoxy)-benzenemethanol

C22H25NO2 (335.1885)


   
   
   
   
   
   

hydroxychloroquine

hydroxychloroquine

C18H26ClN3O (335.1764)


P - Antiparasitic products, insecticides and repellents > P01 - Antiprotozoals > P01B - Antimalarials > P01BA - Aminoquinolines COVID info from Guide to PHARMACOLOGY, clinicaltrial, clinicaltrials, clinical trial, clinical trials D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C277 - Antiprotozoal Agent D018501 - Antirheumatic Agents D004791 - Enzyme Inhibitors Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS CONFIDENCE standard compound; INTERNAL_ID 2741

   
   
   
   
   
   
   
   

JWH 201

2-(4-methoxyphenyl)-1-(1-pentyl-1H-indol-3-yl)-ethanone

C22H25NO2 (335.1885)


   
   

N-Cinnamoyl-p-prenyloxyphenethylamine

(2Z)-N-(2-{4-[(3-methylbut-2-en-1-yl)oxy]phenyl}ethyl)-3-phenylprop-2-enamide

C22H25NO2 (335.1885)


   

4-(4-nitrophenethyl)piperazine-1-carboxylic acid tert butyl ester

4-(4-nitrophenethyl)piperazine-1-carboxylic acid tert butyl ester

C17H25N3O4 (335.1845)


   

4-(4-nitrobenzylamino)piperidine-1-carboxylic acid tert-butyl ester

4-(4-nitrobenzylamino)piperidine-1-carboxylic acid tert-butyl ester

C17H25N3O4 (335.1845)


   

(4-BENZYLOXY-BENZYL)-HYDRAZINE

(4-BENZYLOXY-BENZYL)-HYDRAZINE

C17H25N3O4 (335.1845)


   

(3S,4S)-BENZYL 3-AMINO-4-((TERT-BUTOXYCARBONYL)AMINO)PYRROLIDINE-1-CARBOXYLATE

(3S,4S)-BENZYL 3-AMINO-4-((TERT-BUTOXYCARBONYL)AMINO)PYRROLIDINE-1-CARBOXYLATE

C17H25N3O4 (335.1845)


   
   

N-(ADAMANTAN-2-YL)-2-(NAPHTHALEN-2-YLOXY)ACETAMIDE

N-(ADAMANTAN-2-YL)-2-(NAPHTHALEN-2-YLOXY)ACETAMIDE

C22H25NO2 (335.1885)


   

(4-BENZYLOXY-3-METHOXY-BENZYL)-HYDRAZINE

(4-BENZYLOXY-3-METHOXY-BENZYL)-HYDRAZINE

C17H25N3O4 (335.1845)


   

1-BOC-4-(CARBOXY-PYRIDIN-4-YL-METHYL)-[1,4]DIAZEPANE

1-BOC-4-(CARBOXY-PYRIDIN-4-YL-METHYL)-[1,4]DIAZEPANE

C17H25N3O4 (335.1845)


   

1-BOC-4-(CARBOXY-PYRIDIN-3-YL-METHYL)-[1,4]DIAZEPANE

1-BOC-4-(CARBOXY-PYRIDIN-3-YL-METHYL)-[1,4]DIAZEPANE

C17H25N3O4 (335.1845)


   

3-BROMOBENZYLSULFONYLCHLORIDE

3-BROMOBENZYLSULFONYLCHLORIDE

C17H25N3O4 (335.1845)


   

Diphenyltropine

Diphenyltropine

C22H25NO2 (335.1885)


   

Benzoic acid,2-[[2-(phenylmethylene)heptylidene]amino]-, methyl ester

Benzoic acid,2-[[2-(phenylmethylene)heptylidene]amino]-, methyl ester

C22H25NO2 (335.1885)


   

N-(2,2-DIMETHOXY-ETHYL)-4-(4,4,5,5-TETRAMETHYL-[1,3,2]DIOXABOROLAN-2-YL)-BENZAMIDE

N-(2,2-DIMETHOXY-ETHYL)-4-(4,4,5,5-TETRAMETHYL-[1,3,2]DIOXABOROLAN-2-YL)-BENZAMIDE

C17H26BNO5 (335.1904)


   

dl-leucyl-glycyl-dl-phenylalanine

dl-leucyl-glycyl-dl-phenylalanine

C17H25N3O4 (335.1845)


   

(R)-BOROPHE-(+)-PINANEDIOL

(R)-BOROPHE-(+)-PINANEDIOL

C18H27BClNO2 (335.1823)


   

3-phenyl-1-(6,7,8,9-tetrahydrobenzo[g][1,3]benzodioxol-6-ylmethyl)pyrrolidine

3-phenyl-1-(6,7,8,9-tetrahydrobenzo[g][1,3]benzodioxol-6-ylmethyl)pyrrolidine

C22H25NO2 (335.1885)


   

Methyl 4-{5-[bis(2-hydroxyethyl)amino]-1-methyl-1H-benzimidazol-2 -yl}butanoate

Methyl 4-{5-[bis(2-hydroxyethyl)amino]-1-methyl-1H-benzimidazol-2 -yl}butanoate

C17H25N3O4 (335.1845)


   

4-(5-ETHOXYCARBONYL-PYRIDIN-2-YL)-PIPERAZINE-1-CARBOXYLIC ACID TERT-BUTYL ESTER

4-(5-ETHOXYCARBONYL-PYRIDIN-2-YL)-PIPERAZINE-1-CARBOXYLIC ACID TERT-BUTYL ESTER

C17H25N3O4 (335.1845)


   

tert-Butyl 4-(2-nitrobenzylamino)piperidine-1-carboxylate

tert-Butyl 4-(2-nitrobenzylamino)piperidine-1-carboxylate

C17H25N3O4 (335.1845)


   

(S)-5-[(Biphenyl-4-yl)methyl]-1-(2,2-dimethylpropionyl)pyrrolidin-2-one

(S)-5-[(Biphenyl-4-yl)methyl]-1-(2,2-dimethylpropionyl)pyrrolidin-2-one

C22H25NO2 (335.1885)


   

Valsartan EP impurity 7

Valsartan EP impurity 7

C19H21N5O (335.1746)


   

4-(3-(tert-butoxycarbonyl(cyclopropyl)aMino)propoxy)phenylboronic acid

4-(3-(tert-butoxycarbonyl(cyclopropyl)aMino)propoxy)phenylboronic acid

C17H26BNO5 (335.1904)


   

9-(2-ETHYLHEXYL)CARBAZOLE-3 6-DICARBOXA&

9-(2-ETHYLHEXYL)CARBAZOLE-3 6-DICARBOXA&

C22H25NO2 (335.1885)


   
   

Carycinel Red

Carycinel Red

C22H25NO2 (335.1885)


   

4-CYANOPHENYL 4-OCTYLBENZOATE

4-CYANOPHENYL 4-OCTYLBENZOATE

C22H25NO2 (335.1885)


   

tert-Butyl 4-(((2-nitrophenyl)amino)methyl)piperidine-1-carboxylate

tert-Butyl 4-(((2-nitrophenyl)amino)methyl)piperidine-1-carboxylate

C17H25N3O4 (335.1845)


   

N-(4,4-Diphenyl-3-butenyl)nipecotic acid

N-(4,4-Diphenyl-3-butenyl)nipecotic acid

C22H25NO2 (335.1885)


D002491 - Central Nervous System Agents > D000927 - Anticonvulsants D018377 - Neurotransmitter Agents > D018682 - GABA Agents

   

GLYCYL-leucyl-phenylalanine

GLYCYL-leucyl-phenylalanine

C17H25N3O4 (335.1845)


   

H-Gly-phe-leu-OH

H-Gly-phe-leu-OH

C17H25N3O4 (335.1845)


   

(2S)-2-[[2-[[(2S)-2-amino-4-methylpentanoyl]amino]acetyl]amino]-3-phenylpropanoic acid

(2S)-2-[[2-[[(2S)-2-amino-4-methylpentanoyl]amino]acetyl]amino]-3-phenylpropanoic acid

C17H25N3O4 (335.1845)


   

(3r,4s)-1-[(4-Amino-5h-Pyrrolo[3,2-D]pyrimidin-7-Yl)methyl]-4-[(Butylsulfanyl)methyl]pyrrolidin-3-Ol

(3r,4s)-1-[(4-Amino-5h-Pyrrolo[3,2-D]pyrimidin-7-Yl)methyl]-4-[(Butylsulfanyl)methyl]pyrrolidin-3-Ol

C16H25N5OS (335.178)


   

2-(4-Methoxyphenyl)-1-(1-pentylindol-3-YL)ethanone

2-(4-Methoxyphenyl)-1-(1-pentylindol-3-YL)ethanone

C22H25NO2 (335.1885)


   

alpha-Pentyl-3-(2-quinolinylmethoxy)benzenemethanol

alpha-Pentyl-3-(2-quinolinylmethoxy)benzenemethanol

C22H25NO2 (335.1885)


D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D006401 - Hematologic Agents > D010975 - Platelet Aggregation Inhibitors D004791 - Enzyme Inhibitors > D016859 - Lipoxygenase Inhibitors D002491 - Central Nervous System Agents > D000700 - Analgesics D020011 - Protective Agents > D000975 - Antioxidants D000893 - Anti-Inflammatory Agents D018501 - Antirheumatic Agents

   

Strychnine(1+)

Strychnine(1+)

C21H23N2O2+ (335.1759)


An indole alkaloid cation obtained by protonation of the tertiary amino group of strychnine.

   

4-[3-(4-Methoxyanilino)-3-oxopropyl]-1-piperazinecarboxylic acid ethyl ester

4-[3-(4-Methoxyanilino)-3-oxopropyl]-1-piperazinecarboxylic acid ethyl ester

C17H25N3O4 (335.1845)


   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

N-2-[4-(3,3-Dimethylallyloxy)phenyl]ethylcinnamide

N-2-[4-(3,3-Dimethylallyloxy)phenyl]ethylcinnamide

C22H25NO2 (335.1885)


   
   
   
   

PPARγ-IN-2

PPARγ-IN-2

C19H21N5O (335.1746)


PPARγ-IN-2 (Compound 5a) is a PPARγ inhibitor. PPARγ-IN-2 inhibits TG accumulation in 3T3-L1 preadipocytes (EC50: 0.106 μM). PPARγ-IN-2 inhibits high-cholesterol diet (HFC)-induced obesity and related metabolic syndrome, and reduces lipid accumulation in adipose tissue[1].

   

5-(3-amino-3-carboxypropyl)-1h,2h,3h,8h,9h,10h,11h,11ah,11bh-pyrido[2,1-f]1,6-naphthyridine-8-carboxylic acid

5-(3-amino-3-carboxypropyl)-1h,2h,3h,8h,9h,10h,11h,11ah,11bh-pyrido[2,1-f]1,6-naphthyridine-8-carboxylic acid

C17H25N3O4 (335.1845)


   

(3s,11as,11bs)-5-[(3s)-3-amino-3-carboxypropyl]-1h,2h,3h,8h,9h,10h,11h,11ah,11bh-pyrido[2,1-f]1,6-naphthyridine-3-carboxylic acid

(3s,11as,11bs)-5-[(3s)-3-amino-3-carboxypropyl]-1h,2h,3h,8h,9h,10h,11h,11ah,11bh-pyrido[2,1-f]1,6-naphthyridine-3-carboxylic acid

C17H25N3O4 (335.1845)


   

(1r,2r,3r,5s)-2-benzyl-8-methyl-8-azabicyclo[3.2.1]octan-3-yl benzoate

(1r,2r,3r,5s)-2-benzyl-8-methyl-8-azabicyclo[3.2.1]octan-3-yl benzoate

C22H25NO2 (335.1885)


   

(3s,11ar,11br)-5-[(3s)-3-amino-3-carboxypropyl]-1h,2h,3h,8h,9h,10h,11h,11ah,11bh-pyrido[2,1-f]1,6-naphthyridine-3-carboxylic acid

(3s,11ar,11br)-5-[(3s)-3-amino-3-carboxypropyl]-1h,2h,3h,8h,9h,10h,11h,11ah,11bh-pyrido[2,1-f]1,6-naphthyridine-3-carboxylic acid

C17H25N3O4 (335.1845)


   

2-benzyl-8-methyl-8-azabicyclo[3.2.1]octan-3-yl benzoate

2-benzyl-8-methyl-8-azabicyclo[3.2.1]octan-3-yl benzoate

C22H25NO2 (335.1885)


   

(3s,11as,11br)-5-[(3s)-3-amino-3-carboxypropyl]-1h,2h,3h,8h,9h,10h,11h,11ah,11bh-pyrido[2,1-f]1,6-naphthyridine-3-carboxylic acid

(3s,11as,11br)-5-[(3s)-3-amino-3-carboxypropyl]-1h,2h,3h,8h,9h,10h,11h,11ah,11bh-pyrido[2,1-f]1,6-naphthyridine-3-carboxylic acid

C17H25N3O4 (335.1845)


   

2-[1-methyl-6-(2-oxo-2-phenylethyl)piperidin-2-yl]-1-phenylethanone

2-[1-methyl-6-(2-oxo-2-phenylethyl)piperidin-2-yl]-1-phenylethanone

C22H25NO2 (335.1885)


   

n-(2-{4-[(3-methylbut-2-en-1-yl)oxy]phenyl}ethyl)-3-phenylprop-2-enimidic acid

n-(2-{4-[(3-methylbut-2-en-1-yl)oxy]phenyl}ethyl)-3-phenylprop-2-enimidic acid

C22H25NO2 (335.1885)


   

(8r,11ar,11bs)-5-[(3r)-3-amino-3-carboxypropyl]-1h,2h,3h,8h,9h,10h,11h,11ah,11bh-pyrido[2,1-f]1,6-naphthyridine-8-carboxylic acid

(8r,11ar,11bs)-5-[(3r)-3-amino-3-carboxypropyl]-1h,2h,3h,8h,9h,10h,11h,11ah,11bh-pyrido[2,1-f]1,6-naphthyridine-8-carboxylic acid

C17H25N3O4 (335.1845)


   

(3s,11ar,11bs)-5-[(3s)-3-amino-3-carboxypropyl]-1h,2h,3h,8h,9h,10h,11h,11ah,11bh-pyrido[2,1-f]1,6-naphthyridine-3-carboxylic acid

(3s,11ar,11bs)-5-[(3s)-3-amino-3-carboxypropyl]-1h,2h,3h,8h,9h,10h,11h,11ah,11bh-pyrido[2,1-f]1,6-naphthyridine-3-carboxylic acid

C17H25N3O4 (335.1845)


   

(2e)-n-(2-{4-[(3-methylbut-2-en-1-yl)oxy]phenyl}ethyl)-3-phenylprop-2-enimidic acid

(2e)-n-(2-{4-[(3-methylbut-2-en-1-yl)oxy]phenyl}ethyl)-3-phenylprop-2-enimidic acid

C22H25NO2 (335.1885)


   

(4s,8z,11s,12e)-11-hydroxy-4,12-dimethyl-13-(2-methyl-1,3-thiazol-4-yl)trideca-8,12-dien-3-one

(4s,8z,11s,12e)-11-hydroxy-4,12-dimethyl-13-(2-methyl-1,3-thiazol-4-yl)trideca-8,12-dien-3-one

C19H29NO2S (335.1919)


   

5-(3-amino-3-carboxypropyl)-1h,2h,3h,8h,9h,10h,11h,11ah,11bh-pyrido[2,1-f]1,6-naphthyridine-3-carboxylic acid

5-(3-amino-3-carboxypropyl)-1h,2h,3h,8h,9h,10h,11h,11ah,11bh-pyrido[2,1-f]1,6-naphthyridine-3-carboxylic acid

C17H25N3O4 (335.1845)


   

4-[2-(4-fluorophenyl)-5-(1-methylpiperidin-4-yl)-1h-pyrrol-3-yl]pyridine

4-[2-(4-fluorophenyl)-5-(1-methylpiperidin-4-yl)-1h-pyrrol-3-yl]pyridine

C21H22FN3 (335.1798)